Correlation and Risk Assessment of Inflammation-Based Parameters on Cardiovascular Parameters and Clinical Events in

Leyla Schweiger1, Andreas Meinitzer2, Dieter Szolar3

  • 1Division of Angiology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.

Insights

In patients with inactive giant cell arteritis (GCA), elevated white blood cells and neutrophils correlate with endothelial dysfunction and predict disease relapse. Other inflammatory markers did not predict cardiovascular events or mortality.

Area of Science:

  • Rheumatology
  • Immunology
  • Cardiovascular Medicine

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis affecting large arteries.
  • Endothelial dysfunction and lipid abnormalities are common in GCA.
  • Inflammation-based biomarkers may offer insights into GCA pathogenesis and prognosis.

Purpose of the Study:

  • To investigate associations between inflammation biomarkers, endothelial dysfunction, and lipids in GCA.
  • To determine the predictive value of these biomarkers for clinical outcomes in GCA patients.

Main Methods:

  • Retrospective analysis of 138 patients with inactive GCA.
  • Assessment of inflammatory biomarkers, endothelial dysfunction markers, and lipid parameters.
  • Logistic regression analysis to evaluate predictive value for clinical outcomes.

Main Results:

  • Higher white blood cell and neutrophil counts were observed in GCA patients without polymyalgia rheumatica symptoms or those receiving initial glucocorticoid pulse therapy.
  • Significant correlations were found between inflammation-based ratios, endothelial dysfunction markers, and lipid parameters.
  • Elevated white blood cells and neutrophils independently predicted disease relapse in GCA patients.

Conclusions:

  • Selected inflammatory parameters correlate with endothelial dysfunction and dyslipidemia in inactive GCA.
  • White blood cells and neutrophils are significant predictors of disease relapse in GCA.
  • No significant associations were found between inflammatory biomarkers and cardiovascular events, mortality, or glucocorticoid adverse effects.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
59
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
58
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.2K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
40
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
216
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
78